These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12787920)

  • 1. Human tissue factor pathway inhibitor-2 does not bind or inhibit activated matrix metalloproteinase-1.
    Du X; Chand HS; Kisiel W
    Biochim Biophys Acta; 2003 Jun; 1621(3):242-5. PubMed ID: 12787920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration.
    Zhao B; Luo X; Shi H; Ma D
    Thromb Res; 2011 Aug; 128(2):179-85. PubMed ID: 21458846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor.
    Rao CN; Mohanam S; Puppala A; Rao JS
    Biochem Biophys Res Commun; 1999 Feb; 255(1):94-8. PubMed ID: 10082661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis.
    Herman MP; Sukhova GK; Kisiel W; Foster D; Kehry MR; Libby P; Schönbeck U
    J Clin Invest; 2001 May; 107(9):1117-26. PubMed ID: 11342575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2.
    Rao CN; Reddy P; Reeder DJ; Liu Y; Stack SM; Kisiel W; Woodley DT
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1286-94. PubMed ID: 11027624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alpha 2 chain of collagen type VI sequesters latent proforms of matrix-metalloproteinases and modulates their activation and activity.
    Freise C; Erben U; Muche M; Farndale R; Zeitz M; Somasundaram R; Ruehl M
    Matrix Biol; 2009 Oct; 28(8):480-9. PubMed ID: 19698785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid attenuates cytokine-driven fibroblast degradation of extracellular matrix in three-dimensional culture.
    Zhu YK; Liu X; Ertl RF; Kohyama T; Wen FQ; Wang H; Spurzem JR; Romberger DJ; Rennard SI
    Am J Respir Cell Mol Biol; 2001 Nov; 25(5):620-7. PubMed ID: 11713105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure, function and biology of tissue factor pathway inhibitor-2.
    Chand HS; Foster DC; Kisiel W
    Thromb Haemost; 2005 Dec; 94(6):1122-30. PubMed ID: 16411383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
    Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
    Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-alpha and neutrophil elastase.
    Kohyama T; Liu X; Zhu YK; Wen FQ; Wang HJ; Fang Q; Kobayashi T; Rennard SI
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):487-94. PubMed ID: 12356583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of heparin and related glycosaminoglycan on PDGF-induced lung fibroblast proliferation, chemotactic response and matrix metalloproteinases activity.
    Sasaki M; Kashima M; Ito T; Watanabe A; Sano M; Kagaya M; Shioya T; Miura M
    Mediators Inflamm; 2000; 9(2):85-91. PubMed ID: 10958381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycation cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice.
    Kuzuya M; Asai T; Kanda S; Maeda K; Cheng XW; Iguchi A
    Diabetologia; 2001 Apr; 44(4):433-6. PubMed ID: 11357473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.
    Cunningham AC; Hasty KA; Enghild JJ; Mast AE
    Biochem J; 2002 Oct; 367(Pt 2):451-8. PubMed ID: 12117418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutis laxa: analysis of metalloproteinases and extracellular matrix expression by immunohistochemistry and histochemistry.
    Gu W; Liu W; Yang X; Yuan X; Tian Y; Meng R; Zhao Q
    Eur J Dermatol; 2011; 21(5):717-21. PubMed ID: 21719403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension.
    Lepetit H; Eddahibi S; Fadel E; Frisdal E; Munaut C; Noel A; Humbert M; Adnot S; D'Ortho MP; Lafuma C
    Eur Respir J; 2005 May; 25(5):834-42. PubMed ID: 15863640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion.
    Iochmann S; Bléchet C; Chabot V; Saulnier A; Amini A; Gaud G; Gruel Y; Reverdiau P
    Clin Exp Metastasis; 2009; 26(5):457-67. PubMed ID: 19267203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of tissue inhibitor of matrix metalloproteinases-4 on the activities of matrix metalloproteinases and collagen of artery: experiment with rats].
    Zu LY; Guo YH; Chen L; Li Q; Yan H; Gao W
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):472-5. PubMed ID: 16677575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP
    Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of TFPI-2 promotes migration and invasion of glioma cells.
    Gessler F; Voss V; Seifert V; Gerlach R; Kögel D
    Neurosci Lett; 2011 Jun; 497(1):49-54. PubMed ID: 21530612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes.
    Izumi H; Takahashi C; Oh J; Noda M
    FEBS Lett; 2000 Sep; 481(1):31-6. PubMed ID: 10984610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.